D. Faggion

A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet (gestodene75/EE20) on body fat.

N. R. de Melo, J. Aldrighi, C. Fernandes, 2004, Contraception.

Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).

E. Baracat, I. Barbosa, D. Faggion, 2006, Contraception.